Evidence map›Paper›PMID 22041062›Full record

ArticleBioorganic & medicinal chemistry letters2011

Synthetase polyspecificity as a tool to modulate protein function.

Douglas D Young, Steffen Jockush, Nicholas J Turro, Peter G Schultz

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Reprogramming the genetic code.Nature reviews. Genetics · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Playing with the Molecules of Life.ACS chemical biology · 2018
    Review
  12. Article
  13. Article
  14. Utilization of alkyne bioconjugations to modulate protein function.Bioorganic & medicinal chemistry letters · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Douglas D YoungDepartment of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
Steffen Jockush
Nicholas J Turro
Peter G Schultz
Columbia University · USScripps Research Institute · US

Funding

Development of Novel Immunoconjugates for Application in Cancer TherapeuticsF32CA144213 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI YOUNG, DOUGLAS DEAN · 2009 to 2010
$86k
NCI NIH HHS F32 CA144213NCI NIH HHS F32CA144213
6 · The paper itself

Abstract

The site-specific incorporation of unnatural amino acids (UAAs) into proteins in bacteria is made possible by the evolution of aminoacyl-tRNA synthetases that selectively recognize and aminoacylate the amino acid of interest. Recently we have discovered that some of the previously evolved aaRSs display a degree of polyspecificity and are capable of recognizing multiple UAAs. Herein we report the polyspecificity of an aaRS evolved to encode a comarin containing amino acid. This polyspecificity was then exploited to introduce several UAAs into the fluorophore of GFP, altering its photophysical properties.

Indexed as

Amino AcidsAmino Acyl-tRNA SynthetasesBacteriaGreen Fluorescent ProteinsSubstrate SpecificityAmino AcidsAmino Acyl-tRNA SynthetasesGreen Fluorescent Proteins

Identifiers

PMID22041062
PMCPMC3783217
OpenAlexW1989255556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.